Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Ivermectin  COVID-19 treatment studies for Ivermectin  C19 studies: Ivermectin  Ivermectin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Ivermectin is associated with increase in SPO2 in hypoxemic SARS-CoV-2 patients: pharmacodynamic profile and correlates
Babalola et al., Research Square, doi:10.21203/rs.3.rs-1576399/v1 (Preprint)
Babalola et al., Ivermectin is associated with increase in SPO2 in hypoxemic SARS-CoV-2 patients: pharmacodynamic profile and.., Research Square, doi:10.21203/rs.3.rs-1576399/v1 (Preprint)
Apr 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Extended analysis of [Thairu], showing significantly faster and greater improvement in SpO2 with ivermectin treatment.
Babalola et al., 27 Apr 2022, preprint, 6 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperIvermectinAll
Abstract: Ivermectin is associated with increase in SPO2 in hypoxemic SARS-Cov-2 patients: pharmacodynamic profile and correlates. olufemi Emmanuel Babalola (  bablo57@gmail.com ) Bingham University, New Karu https://orcid.org/0000-0001-7737-3831 Adesuyi A. Ajayi Baylor College, Texas https://orcid.org/0000-0003-2036-7929 Thairu Yunusa University of Abuja https://orcid.org/0000-0003-1941-8151 Yahaya Ndanusa Al Ummah Foundation, Abuja John O. Ogedengbe University of Abuja https://orcid.org/0000-0002-1559-1750 Omede Ogu Federal Ministry of Health, Abuja https://orcid.org/0000-0001-6695-1405 Research Article Keywords: Ivermectin, arterial oxygen saturation, covid-19, viral load Posted Date: April 27th, 2022 DOI: https://doi.org/10.21203/rs.3.rs-1576399/v1 License:   This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/20 Abstract Background and Objectives: Hypoxemic respiratory failure is a common mode of demise in Covid 19 disease. We aimed to describe the time course of SPO2 changes in Covid 19 patients treated with and without ivermectin. Methods: This was a parallel group, prospective comparative study of propensity matched Covid 19 patients (Cycle threshold Ct < 25, SPO2 < 94%). 21 of the patients received Ivermectin (IVM) inclusive regime at 12 mg daily for 5 days, while 26 others received Non-ivermectin inclusive regime ( NIVM). Results: the IVM group demonstrated earlier and greater increase in SPO2 (p=0.000) which paralleled greater and faster virological clearance (p = 0.000) on Repeat measures Analysis of Variance RMANOVA. There was a significant correlation between absolute SPO2 and absolute Ct on day 5 (r = 0.77 ) and day 7 (r = 0.77) both p = 0.000. Incremental SPO2 also correlated with incremental Ct. by day 5 ( r = 0.397, p = 0.003) and day 7 ( r = 0.315 , p = 0.0002) relative to baseline. Increase in platelet count correlated with increased SPO2 (r = 0.252, p = 0.029) on IVM, but negatively with NIVM (r = - 0.28, p = 0 .17). Inflammatory markers such as ESR, CRP or D- dimer showed no significant correlation with SPO2. Increase in SPO2 on IVM was magnified in males. Conclusion: IVM regime appears to be associated with faster and greater increase in SPO2 paralleling faster viral clearance in Covid 19 patients.
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit